Human Metabolome Technologies, Inc. (TYO:6090)
691.00
-1.00 (-0.14%)
Apr 25, 2025, 3:30 PM JST
TYO:6090 Revenue
Human Metabolome Technologies had revenue of 410.00M JPY in the quarter ending December 31, 2024, with 3.27% growth. This brings the company's revenue in the last twelve months to 1.40B, up 5.75% year-over-year. In the fiscal year ending June 30, 2024, Human Metabolome Technologies had annual revenue of 1.35B with 3.54% growth.
Revenue (ttm)
1.40B
Revenue Growth
+5.75%
P/S Ratio
2.92
Revenue / Employee
24.09M
Employees
58
Market Cap
4.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.35B | 46.00M | 3.54% |
Jun 30, 2023 | 1.30B | 76.00M | 6.21% |
Jun 30, 2022 | 1.22B | 99.00M | 8.81% |
Jun 30, 2021 | 1.12B | 6.00M | 0.54% |
Jun 30, 2020 | 1.12B | 279.00M | 33.25% |
Jun 30, 2019 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Shionogi & | 456.87B |